We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
(+4.6%)
Cap. Flow
-$5.41B
Cap. Flow
% of AUM
-23.63%
Top 10 Holdings %
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.8M |
| 2 |
Apple
AAPL
|
+$35.4M |
| 3 |
Amazon
AMZN
|
+$34.6M |
| 4 |
AESC
The AES Corporation
AESC
|
+$30.3M |
| 5 |
Adobe
ADBE
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$236M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$25M |
| 4 |
Applied Materials
AMAT
|
+$22.1M |
| 5 |
Baxter International
BAX
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Financials | 8.11% |
| 3 | Healthcare | 7.32% |
| 4 | Consumer Discretionary | 6.91% |
| 5 | Communication Services | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Amgen
AMGN
$203B
| $18M | 0.08% |
84,621
+7,467
| +10% | +$1.72M |
|
177
TSMC
TSM
$2.07T
| $17.9M | 0.08% |
160,559
+4,752
| +3% | +$558K |
|
178
Becton Dickinson
BDX
$43.8B
| $17.9M | 0.08% |
74,506
+6,912
| +10% | +$1.7M |
|
179
Williams Companies
WMB
$86.6B
| $17.8M | 0.08% |
688,042
+223,949
| +48% | +$5.64M |
|
180
AstraZeneca
AZN
$263B
| $17.8M | 0.08% |
+148,454
| New | +$17.3M |
|
181
Air Products & Chemicals
APD
$65.2B
| $17.8M | 0.08% |
69,601
+6,141
| +10% | +$1.7M |
|
182
Zions Bancorporation
ZION
$10B
| $17.3M | 0.08% |
279,161
+24,630
| +10% | +$1.35M |
|
183
Quanta Services
PWR
$93.1B
| $17M | 0.07% |
149,531
+138,027
| +1,200% | +$13.8M |
|
184
Autodesk
ADSK
$47.7B
| $16.9M | 0.07% |
59,142
+5,219
| +10% | +$1.6M |
|
185
VF Corp
VFC
$6.72B
| $16.8M | 0.07% |
251,350
+148,818
| +145% | +$11.4M |
|
186
Truist Financial
TFC
$63.7B
| $16.8M | 0.07% |
286,523
-18,208
| -6% | -$1.02M |
|
187
Southwest Airlines
LUV
$22.2B
| $16.5M | 0.07% |
321,551
+17,202
| +6% | +$869K |
|
188
SLB Ltd
SLB
$76.5B
| $16M | 0.07% |
538,505
+22,703
| +4% | +$650K |
|
189
Gartner
IT
$9.87B
| $15.6M | 0.07% |
51,259
+4,523
| +10% | +$1.31M |
|
190
JB Hunt Transport Services
JBHT
$26.4B
| $15.6M | 0.07% |
93,026
| – | – |
|
191
O'Reilly Automotive
ORLY
$75.1B
| $15.5M | 0.07% |
380,715
+33,600
| +10% | +$1.34M |
|
192
Arthur J. Gallagher & Co
AJG
$65.1B
| $15.4M | 0.07% |
103,755
+9,155
| +10% | +$1.31M |
|
193
Ameriprise Financial
AMP
$47.6B
| $15.4M | 0.07% |
58,156
+5,132
| +10% | +$1.34M |
|
194
Illinois Tool Works
ITW
$81.9B
| $15.3M | 0.07% |
74,012
+6,531
| +10% | +$1.47M |
|
195
CALL
iShares MSCI Japan ETF
EWJ
$21.7B
| $15.3M | 0.07% |
+217,500
| New | +$15.1M |
|
196
Stanley Black & Decker
SWK
$14.6B
| $15.1M | 0.07% |
86,122
+7,599
| +10% | +$1.48M |
|
197
eBay
EBAY
$50.3B
| $15M | 0.07% |
215,849
+19,046
| +10% | +$1.37M |
|
|
BNY
198
Bank of New York Mellon
BNY
$107B
| $15M | 0.07% |
288,647
+19,112
| +7% | +$993K |
|
|
FISV
199
Fiserv Inc
FISV
$27.9B
| $15M | 0.07% |
137,889
+12,167
| +10% | +$1.36M |
|
200
Cemex
CX
$17.6B
| $14.9M | 0.06% |
2,073,043
-211,238
| -9% | -$1.67M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.
- Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
- Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
- Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
- Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
- Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
- Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
- Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.
Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.